News

Biocon’s Itolizumab receives DCGI nod for its use in moderate to severe COVID-19 patients

Itolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru.

Read More

Jul 13, 2020

By : Team ABLE

Numab, Boehringer Ingelheim collaborate to develop multi-specific antibody therapeutics for cancer

The T-cell engager to be developed with Numab adds to Boehringer Ingelheim’s growing cancer immunology portfolio.

Read More

Jul 09, 2020

By : Team ABLE

NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools

The network has developed an extensive community engagement framework to reach out to potential research volunteers

Read More

Jul 09, 2020

By : Team ABLE

ABLE Member Praj announces major Renewable Chemicals and Materials (RCM) portfolio with Bio-Prism product launch

As a part of its newly launched Bio-Prism portfolio, Praj is developing technologies to produce bio-based Renewable Chemicals and Materials (RCM).

Read More

Jul 09, 2020

By : Team ABLE

The European Molecular Biology Organisation extends lifetime membership to NCBS scientist Sumantra Chattarji

It is believed that EMBO bestows lifetime membership to only a few selected scientists across the world who have done outstanding work in their respective fields.

Read More

Jul 09, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights